Geron GERN
NASDAQ GERN
$1.52 -0.03 (-1.94%)
At close: Aug 21, 2026 · 4:00 PM EDT

Geron (GERN) Accumulated Expenses (2010 - 2026)

Geron (GERN) posted Accumulated Expenses of $31.0 million for Q1 2026, up 1.53% sequentially from $30.5 million in Q4 2025, and up 7.2% YoY from $28.9 million in Q1 2025.

Geron (GERN) Accumulated Expenses (2010 - 2026) Analysis & Trends

Geron has reported Accumulated Expenses for 17 years, with the latest figure at $31.0 million in Q1 2026.

  • Quarterly Accumulated Expenses rose 7.2% year-over-year to $31.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $31.0 million (up 7.2% YoY) and the FY2025 annual result came in at $30.5 million, up 33.71% from the prior year.
  • Accumulated Expenses climbed to $31.0 million in Q1 2026 per GERN's latest filing, from $30.5 million in the prior quarter.
  • Over five years, Accumulated Expenses peaked at $53.1 million in Q3 2022 and troughed at $422000.0 in Q2 2022.
  • A 5-year average of $27.5 million and a median of $30.5 million in 2025 frame the typical range for Accumulated Expenses.
  • The sharpest annual moves came in 2022 and 2023: Accumulated Expenses plunged 98.45% in 2022, then soared 10572.04% in 2023.
  • Over 5 years, Accumulated Expenses stood at $33.1 million in 2022, then rose by 21.78% to $40.3 million in 2023, then sank by 43.42% to $22.8 million in 2024, then soared by 33.71% to $30.5 million in 2025, then advanced by 1.53% to $31.0 million in 2026.
  • According to Business Quant data, Accumulated Expenses over the past three periods registered $31.0 million, $30.5 million, and $16.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Geron 1.02 Mn -299.83 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 30.72 Mn
Mar 31, 2026 30.97 Mn
Dec 31, 2025 30.50 Mn
Sep 30, 2025 16.39 Mn
Jun 30, 2025 26.29 Mn
Mar 31, 2025 28.89 Mn
Dec 31, 2024 22.81 Mn
Sep 30, 2024 15.18 Mn
Jun 30, 2024 38.66 Mn
Mar 31, 2024 6.79 Mn
Dec 31, 2023 40.31 Mn
Sep 30, 2023 7.94 Mn
Jun 30, 2023 45.04 Mn
Mar 31, 2023 34.69 Mn
Dec 31, 2022 33.10 Mn
Sep 30, 2022 53.11 Mn
Jun 30, 2022 422,000.00
Mar 31, 2022 35.80 Mn
Dec 31, 2021 8.10 Mn
Sep 30, 2021 6.62 Mn